IMC Chicago LLC Acquires New Shares in Direxion Daily Healthcare Bull 3x Shares $CURE

IMC Chicago LLC acquired a new stake in Direxion Daily Healthcare Bull 3x Shares (NYSEARCA:CURE) in the 3rd quarter, Holdings Channel.com reports. The institutional investor acquired 10,148 shares of the company’s stock, valued at approximately $848,000.

A number of other hedge funds also recently added to or reduced their stakes in the business. Qube Research & Technologies Ltd purchased a new position in Direxion Daily Healthcare Bull 3x Shares during the 2nd quarter valued at about $157,000. SBI Securities Co. Ltd. boosted its stake in shares of Direxion Daily Healthcare Bull 3x Shares by 6.8% during the second quarter. SBI Securities Co. Ltd. now owns 7,612 shares of the company’s stock valued at $600,000 after purchasing an additional 484 shares in the last quarter. Headlands Technologies LLC purchased a new position in Direxion Daily Healthcare Bull 3x Shares during the second quarter valued at approximately $34,000. Rovin Capital UT ADV increased its holdings in Direxion Daily Healthcare Bull 3x Shares by 17.4% during the second quarter. Rovin Capital UT ADV now owns 2,700 shares of the company’s stock valued at $213,000 after buying an additional 400 shares during the period. Finally, Simplex Trading LLC bought a new position in Direxion Daily Healthcare Bull 3x Shares in the second quarter worth approximately $28,000.

Direxion Daily Healthcare Bull 3x Shares Trading Up 5.1%

Shares of NYSEARCA CURE opened at $115.37 on Monday. Direxion Daily Healthcare Bull 3x Shares has a 12-month low of $66.00 and a 12-month high of $123.80. The stock’s fifty day simple moving average is $112.45 and its two-hundred day simple moving average is $96.36. The stock has a market capitalization of $173.06 million, a PE ratio of 20.81 and a beta of 1.91.

Direxion Daily Healthcare Bull 3x Shares Company Profile

The Direxion Daily Healthcare Bull 3X Shares (CURE) is an exchange-traded fund that is based on the Health Care Select Sector index. The fund provides 3x levered exposure to a market cap weighted sub-index of the S&P 500 that tracks the performance of US listed health care companies. CURE was launched on Jun 15, 2011 and is managed by Direxion.